GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Aim Pharm Inc (SZSE:002826) » Definitions » 5-Year Yield-on-Cost %

Tibet Aim Pharm (SZSE:002826) 5-Year Yield-on-Cost % : 1.90 (As of May. 27, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Tibet Aim Pharm 5-Year Yield-on-Cost %?

Tibet Aim Pharm's yield on cost for the quarter that ended in Mar. 2024 was 1.90.


The historical rank and industry rank for Tibet Aim Pharm's 5-Year Yield-on-Cost % or its related term are showing as below:

SZSE:002826' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.44   Med: 0.83   Max: 3.42
Current: 1.9


During the past 10 years, Tibet Aim Pharm's highest Yield on Cost was 3.42. The lowest was 0.44. And the median was 0.83.


SZSE:002826's 5-Year Yield-on-Cost % is ranked worse than
54.18% of 502 companies
in the Drug Manufacturers industry
Industry Median: 2.125 vs SZSE:002826: 1.90

Competitive Comparison of Tibet Aim Pharm's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Tibet Aim Pharm's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tibet Aim Pharm's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tibet Aim Pharm's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Tibet Aim Pharm's 5-Year Yield-on-Cost % falls into.



Tibet Aim Pharm 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Tibet Aim Pharm is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Tibet Aim Pharm  (SZSE:002826) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Tibet Aim Pharm 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Tibet Aim Pharm's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tibet Aim Pharm (SZSE:002826) Business Description

Traded in Other Exchanges
N/A
Address
No. 6, Linqionggang Road, Lhasa Economic and Technological Development Zone, Tibet Autonomous Region, Lhasa, CHN, 850000
Tibet Aim Pharm Inc is the pharmaceutical company based in China. It is mainly engaged in the research and development, production and sales of chemical drugs and proprietary Chinese medicines for common chronic disease such as diabetes and cardiovascular disease as well as medicines for gynecology and obstetrics. The company's products offering includes miglitol tablets, gualoupi injection, nalmefene hydrochloride injection, carbetocin injection; hongjin xiaojie tablets and aceclofenac enteric-coated tablets. The company also expanded its products in the treatment of antibiotic, antiallergic and digestive system.
Executives
Peng Hui Director
Pang Guo Qiang Directors, executives
Li Qian Jin Securities Affairs Representative
Liu Hang Supervisors

Tibet Aim Pharm (SZSE:002826) Headlines

No Headlines